Avidity Partners Management’s Oruka Therapeutics ORKA Stock Holding History

Avidity Partners Management’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$89.3M	Buy	1,520,848 +860,424	+130%	+$29.9M	9.55%	2
2025 Q4	$20M	Hold	660,424	–	–	5.77%	4
2025 Q3	$12.7M	Buy	660,424 +308,300	+88%	+$4.57M	2.89%	5
2025 Q2	$3.95M	Hold	352,124	–	–	0.79%	35
2025 Q1	$3.61M	Hold	352,124	–	–	0.75%	44
2024 Q4	$6.83M	Sell	352,124 -438,802	-55%	-$10.7M	0.68%	48
2024 Q3	$19.4M	Buy	790,926 +707,593	+849%	+$24.6M	0.99%	40
2024 Q2	$3.83M	Buy	+83,333	New	+$3.32M	0.16%	73

Other funds holding ORKA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return